SLC39A13

Across TCGA cell cohorts, SLC39A13 mutation is significantly associated with the RNA expression of many other genes, with 22 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible SLC39A13-associated genes across cancer lineages are MYL7, C20orf85, and BTBD16. Each is linked with SLC39A13 in more than 1 cancer types. Because this analysis shows association rather than direction, both SLC39A13-to-partner and partner-to-SLC39A13 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, MYL7 grouped by SLC39A13-low versus SLC39A13-high in BLOOD_Leukemia.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SLC39A13→partner) and Y-score (partner→SLC39A13) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLOOD_Leukemia	MYL7 →	+0.057	+3.339	<.001	.006	3	1
BLOOD_Leukemia	C20orf85 →	+0.027	+3.969	<.001	.009	3	1
BLOOD_Leukemia	BTBD16 →	+0.108	+4.281	<.001	.001	3	1
BLOOD_Leukemia	PLEKHS1 →	+0.093	+3.551	<.001	.008	3	1
BLOOD_Leukemia	VWC2L →	+0.008	+3.339	.002	.006	3	1
BLOOD_Leukemia	SLC9A4 →	+0.014	+4.147	.006	.008	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 22 associations by consensus.

MYL7 by SLC39A13 expression — BLOOD_Leukemia

Explore this box plot interactively →